BeStock  
Markets › Compare › HRMY vs AUPH

HRMY vs AUPH

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
HRMY · Harmony Biosciences$32.59 ▼ 1.18%
AUPH · Aurinia Pharmaceuticals$14.70 ▼ 1.28%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

728598111124Nov 24, '25May 26, '26Nov 20, '26
  • HRMY -7.6%
  • AUPH -8.8%

Head to head

MetricHRMYAUPH
Price$32.59$14.70
Change today▼ 1.18%▼ 1.28%
Market cap$1.91B$1.97B
Return, 3 months-15.4%-11.3%
Return, year to date-12.9%-7.8%
Return, 1 year-5.0%-6.3%
P/E (TTM)10.86.4
P/B1.83.0
P/E percentile vs own 5y17th67th
Dividend yield––
Revenue growth (YoY, latest qtr)+12.3%+13.9%
Net profit growth (YoY)-5.2%+0.5%
Gross margin74.0%90.6%
Operating margin22.2%48.6%
Net margin18.1%97.7%
Return on equity18.7%61.4%
Analyst target vs. price+45.8%+29.3%
Analyst buy share63%67%
RSI (14)3230
30-day volatility42.9%31.7%
Max drawdown, 1 year-34.5%-21.8%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AUPH is the largest of the group by market value.
  • HRMY has returned the most over the past year.
  • AUPH carries the lowest trailing P/E.
  • AUPH is growing revenue fastest.
  • AUPH keeps the most profit per dollar of sales.
  • AUPH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top